Skip to main content Scroll Top

Alzheimer

REGEnLIFE tests light stimulation on neurodegenerative diseases
Actu 3
REGEnLIFE tests light stimulation on neurodegenerative diseases
Alzheimer Concussions
23 May 2023
REGEnLIFE tests light stimulation on neurodegenerative diseases
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
CTAD-2023
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
Alzheimer Posted Communications
1 December 2022
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
JAD_journal-of-Alzheimer...
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
Alzheimer Scientific Articles
1 November 2022
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Alzheimer Oral Communications
16 September 2021
15th International Conference on Alzheimer’s Disease & Parkinson’s disease (AD/PD) 2021, virtual conference
Photobiomodulation at the Level of Single Neural Cells in Culture
Photobiomodulation at the Level of Single Neural Cells in Culture
Alzheimer Oral Communications
2 January 2021
Photobiomodulation at the Level of Single Neural Cells in Culture
Relevance of photobiomodulation technique in AD treatment
Relevance of photobiomodulation technique in AD treatment
Alzheimer Oral Communications
5 November 2020
Relevance of photobiomodulation technique in AD treatment
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis
Alzheimer Posted Communications
1 December 2019
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis
Alzheimer Posted Communications
30 November 2019
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis
Neuroprotective effect of a new photobiomodulation technique against amyloid Aβ25-35 peptide induced toxicity in mice might support a novel hypothesis for therapeutic approach of Alzheimer’s disease
Neuroprotective effect of a new photobiomodulation technique against amyloid Aβ25-35 peptide induced toxicity in mice might support a novel hypothesis for therapeutic approach of Alzheimer’s disease
Alzheimer Posted Communications
1 October 2019
Neuroprotective effect of a new photobiomodulation technique against amyloid Aβ25-35 peptide induced toxicity in mice might support a novel hypothesis for therapeutic approach of Alzheimer’s disease
Beyond-the-brain’ strategy: a new photobiomodulation technique produces a neuroprotective effect in a mouse model of Alzheimer’s disease by synergistic mechanisms when targeting brain and guts
Beyond-the-brain’ strategy: a new photobiomodulation technique produces a neuroprotective effect in a mouse model of Alzheimer’s disease by synergistic mechanisms when targeting brain and guts
Alzheimer Posted Communications
10 September 2019
Beyond-the-brain’ strategy: a new photobiomodulation technique produces a neuroprotective effect in a mouse model of Alzheimer’s disease by synergistic mechanisms when targeting brain and guts
RegenLife treats Alzheimer’s disease using combined electromagnetic emissions
Actu 16
RegenLife treats Alzheimer’s disease using combined electromagnetic emissions
Alzheimer
3 September 2019
RegenLife treats Alzheimer’s disease using combined electromagnetic emissions
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
Alzheimer Posted Communications
11 July 2019
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
1 2 3